Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) – Suitable For Long Term Buy?
Currently, there are 188.60M common shares owned by the public and among those 186.28M shares have been available to trade. The company’s stock has a 5-day price change of -0.55% and -0.39% over the past three months. BMRN shares are trading -13.11% year to date (YTD), with the 12-month market performance down to -13.04% lower. […]
Is Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Proving The Doubters Wrong?
PRIMECAP Management Co. has recently announced that it has increased stake in Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) by 0.77%. After grabbing 18.38 million shares, the institutional investor is now in possession of 0.14 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.77% having worth around $1.63 billion. Moreover, […]
